Details for Accession #: Q9C0C2


Protein Sequence










Peptide Information

ID Peptide Seq Site Residue Position in Peptide Position in Protein
5386 VSAPGVLTAQDR T 8 819
10002718 813
10014645 VSAPGVLTAQDR S 2 813
10015909 TTAGSVDWTDQLGLR T 1 1154
10024160 TTAGSVDWTDQLGLR T 1154
10027488 VSAPGVLTAQDR S 2 813
10037379 PTSLVQRR 422

O-GlcNAcylation Information

ID Method Analytical Throughput Ambiguity Species Sample Type Condition log2Ratio P Value Data Source PMID Comments
5386 MS HTP ambiguous human HeLa cells 31373491
10002718 MS HTP unambiguous human HeLa cells Mitotic exit/Early mitosis 100 34161081 The p value was -log10p in original paper.
10014645 MS HTP unambiguous human HeLa cells 31373491
10015909 MS HTP unambiguous human liver 31637018
10024160 MS HTP unambiguous human liver 31637018
10027488 MS HTP unambiguous human HeLa cells 35254053
10037379 MS HTP unambiguous human HepG2 cells orafenib sensitive/resistant 2.906890596 30620550 Peptide quantification value was applied to each modification site

ID Peptide Seq Site Residue Position in Peptide Position in Protein Method Analytical Throughput Ambiguity Species Sample Type Data Source PMID Comments
5386 VSAPGVLTAQDR T 8 819 MS HTP ambiguous human HeLa cells 31373491
10002718 813 MS HTP unambiguous human HeLa cells 34161081 The p value was -log10p in original paper.
10014645 VSAPGVLTAQDR S 2 813 MS HTP unambiguous human HeLa cells 31373491
10015909 TTAGSVDWTDQLGLR T 1 1154 MS HTP unambiguous human liver 31637018
10024160 TTAGSVDWTDQLGLR T 1154 MS HTP unambiguous human liver 31637018
10027488 VSAPGVLTAQDR S 2 813 MS HTP unambiguous human HeLa cells 35254053
10037379 PTSLVQRR 422 MS HTP unambiguous human HepG2 cells 30620550 Peptide quantification value was applied to each modification site